Elevated IL-33 levels are associated with conditions such as asthma, inflammatory bowel disease, cardiovascular disorders, and certain cancers, making it a significant biomarker and therapeutic target (Farshadi et al., 2019; Liu et al., 2022; Wang et al., 2023a; Pan et al., 2023; Zhao et al., 2023). This evidence concerns the gene IL33 and cancer.